Wednesday, November 5, 2008

Antares Announces Additional Regulatory Approvals in Europe and Australia for Its Needle-Free Injection Device

Nov 5, 2008 - Antares Pharma, Inc. today announced that it's license partner, Ferring Pharmaceuticals has received additional regulatory approvals in Europe and Australia for use of Antares' needle-free injection devices with it's human growth hormone (hGH), Zomacton.

The details can be read here.

No comments: